Senior/ Clinical Research Fellow ( Christie- Peter Mac)
| Dyddiad hysbysebu: | 23 Mai 2025 |
|---|---|
| Cyflog: | £49,909.00 i £70,425.00 bob blwyddyn |
| Gwybodaeth ychwanegol am y cyflog: | £49909.00 - £70425.00 a year |
| Oriau: | Llawn Amser |
| Dyddiad cau: | 15 Mehefin 2025 |
| Lleoliad: | Manchester, M20 4BX |
| Cwmni: | NHS Jobs |
| Math o swydd: | Cytundeb |
| Cyfeirnod swydd: | C9413-25-0355 |
Crynodeb
DUTIES AND RESPONSIBILITIESThe medical establishment based at The Christie provides 5 Consultant Medical Oncologists, and 3+ Senior/Clinical Fellows within the ECM team. The medical establishment based at Peter MacCullum is integrated into the Department of Medical Oncology; with 7-8 of these Consultant Medical Oncologists acting as Principal Investigators in the Early Drug Development Program, along with 4 Early Drug Development Fellows integrated with the team. Continuing Professional DevelopmentThe Trust supports the requirements for continuing professional development (CPD) as laid down by the GMC and surgical colleges and is committed to providing time and financial support for these activities. Role Planning ROLE: The successful candidate will be recruited as a Clinical Fellow/Senior Clinical Fellow in the Experimental Cancer Medicine Team. The candidate will then undertake the second part of the fellowship at The Peter MacCullum Cancer Centre in Melbourne. The Melbourne element of the fellowship will include a full job description relevant and relative to the Peter MacCullum Cancer Centre based role, and is structured in a similar manner to the role at The Christie. RESEARCH: A diverse range of clinical research trials are in progress and, following training, the post holder will be expected to participate in these studies as a sub-investigator. These include phase I trials of small molecule inhibitors, next-generation chemotherapy trials, combination / multi-modality phase I trials, molecular characterisation / translational studies. The post holder will be involved in managing all aspects of trial patients, through new patient consultation, consent and screening patients and reviewing patients at follow-up appointments. Primarily, patients are seen in the outpatient setting but with some inpatient cover. The appointee is required to attend 4-5 trial outpatient clinics per week (see indicative timetable). The post holder will be expected to attend Safety Review Committee meetings (usually remotely) to discuss trial patients. This will involve close liaison with the trial Principal Investigators, referring consultant body across the Trust and other members of the team. In addition, the post-holder will interface with external stakeholders such as CROs and pharmaceutical sponsors. The post-holder will be expected to attend monthly molecular tumour board meetings to discuss trial patients and to agree opportunities for patients to enroll in early phase trials. PROTOCOLS: The post holder will be expected to undertake the administrative duties associated with the care of their patients. The appointee will be encouraged to harness opportunities to be involved in the development and planning of new studies. PROFESSIONAL DEVELOPMENT: The Clinical Fellow will maintain a level of continuing professional development consistent with the recommendations of the Royal College of Physicians. Appropriate arrangements for study leave will be made in conjunction with colleagues. There is the potential to present research work and the post holder will be expected to be involved in audit, writing papers and reviews. The post holder will also be required to undergo an annual appraisal. TEACHING COMMITMENT: a) UndergraduateThe appointee will be required to contribute to the undergraduate teaching of medical students on oncology topics.b) PostgraduateThere is a busy postgraduate teaching programme and staff are often requested to lecture on relevant topics. The post holder will be expected to contribute actively to the education of junior doctors, specialty trainees and fellows on the team. The post holder will also be expected to help in the training of nursing and multi-disciplinary staff in both in-patient and outpatient departments. CLINICAL GOVERNANCE: The post holder will be expected to participate in all relevant aspects of clinical governance, including maintaining up to date protocols, guidelines and clinical audit, under the supervision of the other consultants in the team. AUDIT: The appointee will play a full role in clinical audit as a member of The Christie Medical Staff Committee. The appointee will develop, supervise and deliver team audit projects. This is a 10 session non-training post funded through The Christie NHS Foundation Trust for an initial period of 1 year, to be followed by an additional year of the fellowship at The Peter MacCullum Cancer Centre in Melbourne with their Phase I/Early Drug Development team.